High Dose Valaciclovir As CMV Prophylaxis in Allogeneic Hematopoietic Stem Cell Recipients at High Risk of CMV Reactivation

被引：0
|
作者：
Douglas, Genevieve
Yong, Michelle K.
Tio, Shio Yen
Chau, Maggie
Sasadeusz, Joe
Slavin, Monica
Xie, Mingdi
Ritchie, David
Chee, Lynette C. Y.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141764
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] CMV disease in CMV-mismatched renal transplant recipients with prophylactic low dose valaciclovir
    Sund, F
    Wahlberg, J
    Eriksson, BM
    JOURNAL OF CLINICAL VIROLOGY, 2001, 23 (1-2) : 107 - 111
  • [42] Efficiency and Risk Factors for CMV Transmission in Seronegative Hematopoietic Stem Cell Recipients
    Pergam, Steven A.
    Xie, Hu
    Sandhu, Ravinder
    Pollack, Margaret
    Smith, Jeremy
    Stevens-Ayers, Terry
    Ilieva, Valeria
    Kimball, Louise E.
    Huang, Meei-Li
    Hayes, Tracy S.
    Corey, Lawrence
    Boeckh, Michael J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (09) : 1391 - 1400
  • [43] Utilization of a CMV T Cell Immunity Panel in Directing Duration of Valganciclovir Prophylaxis in CMV High Risk Kidney Transplant Recipients
    Ray, A.
    Garner, B.
    Klein, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S793 - S793
  • [44] Cost Effectiveness of Letermovir in Prevention of Clinically Significant CMV Infection in CMV Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (04) : 12 - 13
  • [45] An investigation of the utility of plasma Cytomegalovirus (CMV) microRNA detection to predict CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients
    Talaya, Alberto
    Gimenez, Estela
    Pascual, Maria Jesus
    Gago, Beatriz
    Pinana, Jose Luis
    Hernandez-Boluda, Juan Carlos
    Vazquez, Lourdes
    Garcia, Magdalena
    Serrano, David
    Hernandez, Marta
    Albert, Eliseo
    Solano, Carlos
    Navarro, David
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2020, 209 (01) : 15 - 21
  • [46] An investigation of the utility of plasma Cytomegalovirus (CMV) microRNA detection to predict CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients
    Alberto Talaya
    Estela Giménez
    María Jesús Pascual
    Beatriz Gago
    José Luis Piñana
    Juan Carlos Hernández-Boluda
    Lourdes Vázquez
    Magdalena García
    David Serrano
    Marta Hernández
    Eliseo Albert
    Carlos Solano
    David Navarro
    Medical Microbiology and Immunology, 2020, 209 : 15 - 21
  • [47] HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant
    Ghobadia, Armin
    Milton, Denai R.
    Gowda, Lohith
    Rondon, Gabriela
    Chemaly, Roy F.
    Hamdi, Amir
    Alousi, Amin
    Afrough, Aimaz
    Oran, Betul
    Ciurea, Stefan
    Kebriaei, Partow
    Popat, Uday R.
    Qazilbash, Muzaffar H.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Bashir, Qaiser
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2019, 67 (02) : 51 - 55
  • [48] CMV seropositive donor selection for CMV seropositive stem cell transplant recipients reduces CMV reactivation frequency and duration
    Cekauskiene, R.
    Maciutaite, E.
    Lizaitis, M.
    Simutiene, L.
    Trociukas, I.
    Griskevicius, L.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S178 - S178
  • [49] Influence of Donor Cytomegalovirus (CMV) Status on Severity of Viral Reactivation after Allogeneic Stem Cell Transplantation in CMV-Seropositive Recipients
    Pietersma, Floor L.
    van Dorp, Suzanne
    Minnema, Monique C.
    Kuball, Jurgen
    Meijer, Ellen
    Schuurman, Rob
    van Baarle, Debbie
    CLINICAL INFECTIOUS DISEASES, 2011, 52 (07) : E144 - E148
  • [50] CMV MONITORING AND LETERMOVIR PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
    Katayama, Yuta
    Kochi, Yu
    Nunomura, Takuya
    Ikeda, Riichiro
    Hino, Kenjiro
    Imanaka, Ryota
    Kyo, Kohei
    Okatani, Takeshi
    Itagaki, Mitsuhiro
    Katsutani, Shinya
    Muta, Tsuyoshi
    BONE MARROW TRANSPLANTATION, 2024, 59 : 468 - 468
12345